Steel Peak Wealth Management LLC Coherus Bio Sciences, Inc. Transaction History
Steel Peak Wealth Management LLC
- $2.41 Billion
- Q4 2024
A detailed history of Steel Peak Wealth Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 69,000 shares of CHRS stock, worth $63,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,000
Previous 69,000
-0.0%
Holding current value
$63,480
Previous $71,000
33.8%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CHRS
# of Institutions
130Shares Held
67.8MCall Options Held
1.68MPut Options Held
91.8K-
Black Rock Inc. New York, NY11.8MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$10.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.28MShares$4.86 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.84 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA3.65MShares$3.36 Million0.38% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $71.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...